Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-04

Clinical Trial Update: Cannabidiol and Management of Endometriosis Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cannabidiol for endometriosis pain was terminated, with results posted on 2025-04-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Endometriosis, CBD | Phase 3 | Status: TERMINATED | Results posted: 2025-04-04